Financhill
Buy
56

CL Quote, Financials, Valuation and Earnings

Last price:
$92.95
Seasonality move :
0.61%
Day range:
$92.27 - $93.48
52-week range:
$85.32 - $109.30
Dividend yield:
2.17%
P/E ratio:
26.25x
P/S ratio:
3.82x
P/B ratio:
207.49x
Volume:
6.3M
Avg. volume:
5.6M
1-year change:
2.21%
Market cap:
$75.3B
Revenue:
$20.1B
EPS (TTM):
$3.54

Analysts' Opinion

  • Consensus Rating
    Colgate-Palmolive has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 7 Buy ratings, 7 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $98.31, Colgate-Palmolive has an estimated upside of 5.78% from its current price of $92.94.
  • Price Target Downside
    According to analysts, the lowest downside price target is $84.18 representing 9.43% downside risk from its current price of $92.94.

Fair Value

  • According to the consensus of 15 analysts, Colgate-Palmolive has 5.78% upside to fair value with a price target of $98.31 per share.

CL vs. S&P 500

  • Over the past 5 trading days, Colgate-Palmolive has overperformed the S&P 500 by 0.36% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Colgate-Palmolive does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Colgate-Palmolive revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Colgate-Palmolive reported revenues of $4.9B.

Earnings Growth

  • Colgate-Palmolive has grown year-over-year earnings for 7 quarters straight. In the most recent quarter Colgate-Palmolive reported earnings per share of $0.85.
Enterprise value:
82.8B
EV / Invested capital:
--
Price / LTM sales:
3.82x
EV / EBIT:
19.64x
EV / Revenue:
4.15x
PEG ratio (5yr expected):
2.18x
EV / Free cash flow:
23.90x
Price / Operating cash flow:
21.99x
Enterprise value / EBITDA:
17.18x
Gross Profit (TTM):
$12.1B
Return On Assets:
17.55%
Net Income Margin (TTM):
14.52%
Return On Equity:
450.97%
Return On Invested Capital:
32.03%
Operating Margin:
21.91%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $18.3B $19.8B $19.9B $5.1B $4.9B
Gross Profit $10.4B $11.7B $12.1B $3B $3B
Operating Income $3.7B $4.2B $4.4B $1B $1.1B
EBITDA $3.4B $4.4B $4.8B $1.2B $1.2B
Diluted EPS $1.92 $3.16 $3.54 $0.83 $0.85
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $4.6B $5B $5.5B $5.6B $5.8B
Total Assets $15.8B $15.7B $16.2B $16.6B $16.6B
Current Liabilities $4.5B $4.6B $4.4B $5.3B $6.9B
Total Liabilities $15.1B $15B $15.7B $16B $15.9B
Total Equity $663M $728M $425M $617M $733M
Total Debt $7.8B $7.6B $8.9B $8.7B $8.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $2.9B $3.7B $4B $681M $600M
Cash From Investing -$1.7B -$671M -$500M -$193M -$159M
Cash From Financing -$1.1B -$2.8B -$3.5B -$361M -$458M
Free Cash Flow $2.2B $3B $3.5B $555M $476M
CL
Sector
Market Cap
$75.3B
$258.9M
Price % of 52-Week High
85.03%
75.55%
Dividend Yield
2.17%
0%
Shareholder Yield
4.2%
2.89%
1-Year Price Total Return
2.21%
-11.52%
Beta (5-Year)
0.394
0.392
Dividend yield:
2.17%
Annualized payout:
$1.98
Payout ratio:
62.17%
Growth streak:
35 years

Technicals

8-day SMA
Buy
Level $92.07
200-day SMA
Sell
Level $94.58
Bollinger Bands (100)
Buy
Level 87.88 - 93.06
Chaikin Money Flow
Buy
Level 12.3M
20-day SMA
Buy
Level $90.88
Relative Strength Index (RSI14)
Buy
Level 56.28
ADX Line
Buy
Level 11.68
Williams %R
Sell
Level -9.9099
50-day SMA
Buy
Level $91.89
MACD (12, 26)
Buy
Level 2.10
25-day Aroon Oscillator
Sell
Level -48
On Balance Volume
Sell
Level -13.2M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (7.2336)
Sell
CA Score (Annual)
Level (-0.9769)
Buy
Beneish M-Score (Annual)
Level (-2.8775)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (1.3988)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

Stock Forecast FAQ

In the current month, CL has received 7 Buy ratings 7 Hold ratings, and 1 Sell ratings. The CL average analyst price target in the past 3 months is $98.31.

  • Where Will Colgate-Palmolive Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Colgate-Palmolive share price will rise to $98.31 per share over the next 12 months.

  • What Do Analysts Say About Colgate-Palmolive?

    Analysts are divided on their view about Colgate-Palmolive share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Colgate-Palmolive is a Sell and believe this share price will drop from its current level to $84.18.

  • What Is Colgate-Palmolive's Price Target?

    The price target for Colgate-Palmolive over the next 1-year time period is forecast to be $98.31 according to 15 Wall Street analysts, 7 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.

  • Is CL A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Colgate-Palmolive is a Leans Bullish. 7 of 15 analysts rate the stock a Leans Bullish at this time.

  • How Can I Buy Shares Of CL?

    You can purchase shares of Colgate-Palmolive via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Colgate-Palmolive shares.

  • What Is The Colgate-Palmolive Share Price Today?

    Colgate-Palmolive was last trading at $92.95 per share. This represents the most recent stock quote for Colgate-Palmolive. Yesterday, Colgate-Palmolive closed at $92.94 per share.

  • How To Buy Colgate-Palmolive Stock Online?

    In order to purchase Colgate-Palmolive stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock